Castle Biosciences (CSTL) Earnings Date
The next earnings date for Castle Biosciences (CSTL) is around Feb 25, 2027, estimated from its own calendar.
- Next earnings date
- Around Feb 25, 2027
- estimated from its own calendar · quarter ending Dec '26
- Latest stored quarter
- EPS −0.13
- revenue $102.9M · reported Nov 5, 2026
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
1 of 1 scored quarter beat, yet the stock still fell after 1 of them (Nov 5, 2026). The market prices the whole print, not the headline beat. Chasing earnings pops is a coin flip.
| Report | Est EPS | Act EPS | Surprise | Est rev | Act rev | Rev surp. | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 5, 20268-K, after close · 4:05 pm ET | −0.35 | −0.13 | +62.6% | $92.8M | $102.9M | +10.9% | −4.9%next session |
| Jul 30, 20268-K, after close · 4:06 pm ET | — | −0.07 | — | — | $103.5M | — | +4.5%next session |
| May 6, 20268-K, after close · 4:07 pm ET | — | −0.49 | — | — | $83.7M | — | −22.3%next session |
| Feb 26, 20268-K, after close · 4:07 pm ET | — | −0.06 | — | — | $87.0M | — | −7.2%next session |
| Nov 3, 20258-K, after close · 4:14 pm ET | — | −0.02 | — | — | $83.0M | — | +21.7%next session |
| Aug 4, 20258-K, after close · 4:08 pm ET | — | 0.15 | — | — | $86.2M | — | +32.8%next session |
| May 5, 20258-K, after close · 4:09 pm ET | — | −0.90 | — | — | $88.0M | — | −11.4%next session |
| Jan 13, 20258-K, before open · 6:58 am ET | — | 0.32 | — | — | $86.3M | — | −13.6%release day |
Estimate-vs-actual scoring began Aug 2026 and is still accruing: 1 of the 8 quarters above carries a scored estimate. We never backfill an estimate we didn't observe.
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 5 | 4 | 6 | 7 |
| Avg estimate | −0.15 | −0.30 | −0.82 | −0.62 |
| Low estimate | −0.16 | −0.31 | −0.84 | −1.02 |
| High estimate | −0.15 | −0.29 | −0.80 | −0.23 |
| Year-ago EPS | −0.06 | −0.49 | −0.83 | −0.82E |
| Implied growth | — | — | — | — |
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 5 | 4 | 7 | 7 |
| Avg estimate | $101.3M | $101.1M | $389.1M | $433.4M |
| Low estimate | $100.4M | $98.0M | $388.4M | $408.5M |
| High estimate | $102.2M | $104.0M | $390.2M | $467.1M |
| Year-ago revenue | $87.0M | $83.7M | $344.2M | $389.1ME |
| Implied growth | +16.5% | +20.8% | +13.0% | +11.4% |
| Snapshot age | Dec '26, period ending Dec 30, 2026 | Mar '27, period ending Mar 30, 2027 | FY26, period ending Dec 31, 2026 | FY27, period ending Dec 31, 2027 |
|---|---|---|---|---|
| Current estimate | −0.15 | −0.30 | −0.82 | −0.62 |
| 7 days ago | −0.24 | — | −1.04 | −0.67 |
| 30 days ago | −0.36 | — | −1.26 | −0.91 |
| 60 days ago | −0.36 | — | −1.27 | −0.99 |
| 90 days ago | — | — | — | — |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus moved $−0.36 → $−0.15 over 88 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
When does Castle Biosciences report earnings next?
Castle Biosciences' next earnings date is around Feb 25, 2027, estimated from its own calendar.
What were Castle Biosciences' latest quarterly earnings?
Castle Biosciences reported diluted EPS of −0.13 and revenue of $102.9M on Nov 5, 2026.
How did Castle Biosciences' stock move after its last earnings report?
Castle Biosciences moved −4.9% in the session after its Nov 5, 2026 report.

